Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 35, 2005 - Issue 20
154
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis and Biological Evaluation of Novel Isonucleosides with 1,2,4‐Triazole‐3‐Carboxamide

, &
Pages 2653-2663 | Received 18 May 2005, Published online: 22 Aug 2006

References

  • Cummings , K. J. , Lee , S. M. , West , E. S. , Cid‐Ruzafa , J. , Fein , S. J. , Aoki , Y. , Sulkowski , M. S. and Goodman , S. N. 2001 . Interferon and ribavirin vs interferon alone in the re‐treatment of chronic hepatitis C previously nonresponsive to interferon: A meta‐analysis of randomized trials . JAMA, J. Am. Med. Assoc. , 285 : 193
  • Di Bisceglie , A. M. , Thompson , J. , Smith‐Wilkaitis , N. , Brunt , E. M. and Bacon , B. R. 2001 . Combination of interferon and ribavirin in chronic hepatitis C: Re‐treatment of nonresponders to interferon . Hepatology , 33 : 704
  • Krilov , L. R. 2001 . Respiratory syncytial virus: Update on infection, treatment, and prevention . Curr. Infect. Dis. Rep. , 3 : 242
  • Davis , G. L. , Esteban‐Mur , R. , Rustgi , V. , Hoefs , J. , Gordon , S. C. , Trepo , C. , Shiffman , M. L. , Zeuzem , S. , Craxi , A. , Ling , M.‐H. and Albrecht , J. 1998 . Interferon alfa‐2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C . N. Engl. J. Med. , 339 : 1493
  • July 15 1998 . “ 7.5% Virazole® cream approved by the health ministry of the Russian federation [news release] ” . July 15 , Costa Mesa, CA, , USA : ICN Pharmaceuticals Inc .
  • Rico , M. A. , Quiroga , J. A. , Subirá , D. , Castañón , S. , Esteban , J. M. , Pardo , M. and Carreño , V. 2001 . Hepatitis B virus‐specific T‐cell proliferation and cytokine secretion in chronic hepatitis B antibody‐positive patients treated with ribavirin and interferon alpha . Hepatology , 33 : 295
  • Ying , C. , De Clercq , E. and Neyts , J. 2000 . Ribavirin and mycophenolic acid potentiate the activity of guanine‐ and diaminopurine‐based nucleoside analogues against hepatitis B virus . Antiviral Res. , 48 : 117
  • Eugui , E. M. , Almquist , S. T. , Muller , C. D. and Allison , A. C. 1991 . Lymphocyte‐selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion . Scand. J. Immunol. , 33 : 161
  • Franklin , T. J. and Morris , W. P. 1994 . Pharmacodynamics of the inhibition of GTP synthesis in vivo by mycophenolic acid . Adv. Enzyme Regul. , 34 : 107
  • De Clercq , E. 1996 . Non‐nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV‐1) infections: Strategies to overcome drug resistance development . Med. Res. Rev. , 16 : 125
  • Nair , V. and Nuesca , Z. M. 1992 . Isodideoxynucleosides: A conceptually new class of nucleoside antiviral agents . J. Am. Chem. Soc. , 114 : 7951
  • Bolon , P. J. , Sells , T. B. , Nuescu , Z. M. , Purdy , D. F. and Nair , V. 1994 . Novel isomeric dideoxynucleosides as potential antiviral agents . Tetrahedron , 50 : 7747
  • Huryn , D. M. , Sluboski , B. C. , Tam , S. Y. , Todaro , L. J. and Weijele , M. 1989 . Synthesis of iso‐ddA, member of a novel class of anti‐HIV agents . Tetrahedron Lett. , 30 : 6259
  • Huryn , D. M. , Sluboski , B. C. , Tam , S. Y. , Weijele , M. , Sim , I. , Anderson , B. D. , Mitsuya , H. and Broder , S. 1992 . Synthesis and anti‐HIV activity of isonucleosides . J. Med. Chem. , 35 : 2347
  • Bennek , J. A. and Gray , G. R. 1987 . An efficient synthesis of anhydroalditols and allylic‐glycosides . J. Org. Chem. , 52 : 892
  • Jeffery , A. and Nair , V. 1995 . An improved method for the synthesis of anhydroalditols . Tetrahedron Lett. , 36 : 3627
  • Bera , S. and Nair , V. 2001 . A new general synthesis of isomeric nucleosides . Tetrahedron Lett. , 42 : 5813
  • Chun , M. W. , Kim , M. J. , Jo , U. H. , Kim , J. H. , Kim , H.‐D. and Jeong , L. S. 2001 . Synthesis of novel D‐ and L‐3′‐deoxy‐3′‐C‐hydroxymethyl nucleoside with exocyclic methylene as potential ribonucleotide reductase inhibitor . Nucleosides, Nucleotides , 20 : 703

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.